8 participants
Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-12-12
- Start Date:
- 2025-05-16
- Completion:
- 2025-11-20
Conditions
- Breast Cancer
Interventions
- DRUG
No Results Yet